Patients who lost 10% or more of their starting weight on tirzepatide saw bigger gains across cardiometabolic markers, he notes.
Recap by typeshit. Post by Nick Krontiris on X.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Horek told KXAN he went on Wegovy hoping to drop a few stubborn pounds. Months later his story took a turn worth reading in full.
Some studies point to lower risk of certain cancers like breast cancer, but other research suggests the effect may fade over time.
Loading…